Technical Analysis for ACRS - Aclaris Therapeutics, Inc.

Grade Last Price % Change Price Change
F 13.73 -2.28% -0.32
ACRS closed down 2.28 percent on Monday, February 6, 2023, on 2.55 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Feb 22
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
MACD Bearish Centerline Cross Bearish -2.28%
Volume Surge Other -2.28%
Stochastic Reached Oversold Weakness -2.28%
Gapped Up Strength -2.28%
Below Lower BB Weakness -2.28%
Lower Bollinger Band Touch Weakness -2.28%
Oversold Stochastic Weakness -2.28%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 3 hours ago
60 Minute Opening Range Breakdown about 5 hours ago
3x Volume Pace about 7 hours ago
2x Volume Pace about 7 hours ago
1.5x Volume Pace about 7 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Stage Specialty Pharmaceutical Hydrogen Peroxide Topical Medication Common Warts Keratosis

Is ACRS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.9583
52 Week Low 9.84
Average Volume 427,309
200-Day Moving Average 15.36
50-Day Moving Average 16.05
20-Day Moving Average 16.55
10-Day Moving Average 16.03
Average True Range 1.09
RSI 31.97
ADX 20.07
+DI 15.95
-DI 26.41
Chandelier Exit (Long, 3 ATRs) 15.27
Chandelier Exit (Short, 3 ATRs) 16.68
Upper Bollinger Bands 18.85
Lower Bollinger Band 14.25
Percent B (%b) -0.11
BandWidth 27.83
MACD Line -0.35
MACD Signal Line 0.04
MACD Histogram -0.3884
Fundamentals Value
Market Cap 589.28 Million
Num Shares 42.9 Million
EPS -4.17
Price-to-Earnings (P/E) Ratio -3.29
Price-to-Sales 25.00
Price-to-Book 3.76
PEG Ratio -0.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.87
Resistance 3 (R3) 14.89 14.53 14.68
Resistance 2 (R2) 14.53 14.24 14.52 14.62
Resistance 1 (R1) 14.13 14.06 13.95 14.11 14.55
Pivot Point 13.77 13.77 13.68 13.76 13.77
Support 1 (S1) 13.37 13.48 13.19 13.35 12.91
Support 2 (S2) 13.01 13.30 13.00 12.84
Support 3 (S3) 12.61 13.01 12.78
Support 4 (S4) 12.59